Cargando…
Shortage of Nab-paclitaxel in Japan and around the World: Issues in Global Information Sharing
There was a global shortage of nab-paclitaxel (Abraxane(Ⓡ)), a major antineoplastic agent, for a long period (from October 2021 to June 2022) because of manufacturing problems. Japan was one of the first affected countries by the depletion, and the medical institutes started to save the use of the d...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Japan Medical Association
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169259/ https://www.ncbi.nlm.nih.gov/pubmed/37179729 http://dx.doi.org/10.31662/jmaj.2022-0179 |